The hepatitis C virus (HCV) has been studied extensively since its discovery over 15 years ago. Despite challenges in understanding its replication, significant progress has been made, leading to the development of antiviral drugs. HCV replication is complex, involving multiple stages: entry into host cells, translation of its genome, replication of viral RNA, and assembly of new virus particles. The virus replicates efficiently in humans and chimpanzees but was difficult to culture in cell lines until recently. The discovery of HCV's genome sequence and the development of reverse genetics systems have enabled detailed studies of its life cycle. HCV is a positive-sense RNA virus that replicates in the cytoplasm of infected cells, with its genome being translated into a polyprotein that is subsequently cleaved into functional viral proteins. Key enzymes involved in HCV replication include the NS3 serine protease and the NS5B RNA-dependent RNA polymerase. The virus also has a high genetic diversity, with six major genotypes and numerous subtypes. Recent advances in cell culture systems, such as the use of subgenomic replicons, have allowed for the study of HCV replication in vitro. These systems have revealed that HCV replication is highly dependent on specific host factors and that the virus can replicate in a variety of cell types. The replication process involves the formation of a membranous web, which is essential for the virus to replicate efficiently. The virus also interacts with host cell membranes and lipid metabolism, which are critical for its replication. Understanding the mechanisms of HCV replication is crucial for developing effective antiviral therapies. Current research focuses on identifying the factors that contribute to HCV replication and the processes that allow the virus to evade the host immune system. The development of cell culture systems has enabled the study of HCV in greater detail, leading to a better understanding of its life cycle and the factors that contribute to its persistence in the host. This knowledge is essential for the development of new antiviral drugs that target different stages of the virus life cycle.The hepatitis C virus (HCV) has been studied extensively since its discovery over 15 years ago. Despite challenges in understanding its replication, significant progress has been made, leading to the development of antiviral drugs. HCV replication is complex, involving multiple stages: entry into host cells, translation of its genome, replication of viral RNA, and assembly of new virus particles. The virus replicates efficiently in humans and chimpanzees but was difficult to culture in cell lines until recently. The discovery of HCV's genome sequence and the development of reverse genetics systems have enabled detailed studies of its life cycle. HCV is a positive-sense RNA virus that replicates in the cytoplasm of infected cells, with its genome being translated into a polyprotein that is subsequently cleaved into functional viral proteins. Key enzymes involved in HCV replication include the NS3 serine protease and the NS5B RNA-dependent RNA polymerase. The virus also has a high genetic diversity, with six major genotypes and numerous subtypes. Recent advances in cell culture systems, such as the use of subgenomic replicons, have allowed for the study of HCV replication in vitro. These systems have revealed that HCV replication is highly dependent on specific host factors and that the virus can replicate in a variety of cell types. The replication process involves the formation of a membranous web, which is essential for the virus to replicate efficiently. The virus also interacts with host cell membranes and lipid metabolism, which are critical for its replication. Understanding the mechanisms of HCV replication is crucial for developing effective antiviral therapies. Current research focuses on identifying the factors that contribute to HCV replication and the processes that allow the virus to evade the host immune system. The development of cell culture systems has enabled the study of HCV in greater detail, leading to a better understanding of its life cycle and the factors that contribute to its persistence in the host. This knowledge is essential for the development of new antiviral drugs that target different stages of the virus life cycle.